Skip to main content
# Title Department Research Member Research Year
71 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology Dr. Noha gaber sayed 2022
72 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology maureen raafat 2022
73 Neutropenic Fever in Pediatric Patients with Cancer in South Egypt: A Report from a Single Institute Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2022
74 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Anesthesia, Intensive care and Pain management Dr. Neveen Abdelazeem Abdelraheem 2022
75 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
76 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2022
77 Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response Department of Pediatric Oncology Sarah Nour El-dien Obaid Maher 2022
78 Pharmacokinetics and pharmacodynamics of 3 doses of oral-mucosal dexmedetomidine gel for sedative premedication in women undergoing modified radical mastectomy for breast cancer Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2022
79 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Marwa Tammam Ameen Hammam 2022
80 Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022